SCHEMBL7401945

SCHEMBL7401945

CCCC(=O)C1=C(O)CC(C)(C2CC2)OC1=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FASN P49327 4/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ TSHR P16473 3/20 0.35
▸ ALOX12 P18054 1/20 0.35
▸ ALDH1A1 P00352 2/20 0.34
▸ NPSR1 Q6W5P4 2/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ LMNA P02545 3/20 0.33
▸ PTPN1 P18031 2/20 0.32
▸ RECQL P46063 2/20 0.32
▸ MAPT P10636 1/20 0.32
▸ ACP1 P24666 1/20 0.32
▸ CDC25B P30305 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ PTPN2 P17706 1/20 0.32
▸ DUSP3 P51452 1/20 0.32
▸ HPSE Q9Y251 1/20 0.32
▸ HTT P42858 2/20 0.32
▸ ADORA2B P29275 1/20 0.31
▸ POLB P06746 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9687677 0.80 ALDH1A1 (0.34) TSHRALDH1A1KMT2AMAPTHTT
SCHEMBL9687681 0.80 ALDH1A1 (0.34) TSHRALDH1A1KMT2AMAPTHTT
SCHEMBL9686612 0.76 FASN (0.34) FASNSMN1; SMN2TSHRALOX12ALDH1A1
SCHEMBL7402001 0.75 FASN (0.35) FASNSMN1; SMN2TSHRALOX12ALDH1A1
SCHEMBL7401998 0.75 FASN (0.35) FASNSMN1; SMN2TSHRALOX12ALDH1A1
SCHEMBL9687286 0.71 SMN1; SMN2 (0.32) FASNSMN1; SMN2TSHRALOX12
SCHEMBL11131044 0.70 PTPN1 (0.47) ALDH1A1KMT2APTPN1RECQLMAPT
SCHEMBL11742802 0.68 PTPN1 (0.41) FASNSMN1; SMN2TSHRALOX12ALDH1A1
SCHEMBL11074690 0.68 ALDH1A1 (0.54) SMN1; SMN2TSHRALDH1A1LMNAMAPT
SCHEMBL7953371 0.67 ALOX15 (0.42) FASNSMN1; SMN2TSHRALOX12ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0668860-B1 PYRAN-2-ONES AND 5,6-DIHYDROPYRAN-2-ONES USEFUL FOR TREATING HIV AND OTHER RETROVIRUSES UPJOHN CO (US) 2002-09-11 — — EP disclosed
EP-1203770-A1 Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hyperplasia and other diseases PHARMACIA & UPJOHN COMPANY (US) 2002-05-08 — — EP disclosed
US-6169181-B1 HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITORS PHARMACIA & UPJOHN COMPANY 2001-01-02 — — US disclosed
US-5852195-A Pyranone compounds useful to treat retroviral infections PHARMACIA & UPJOHN COMPANY (US) 1998-12-22 — — US disclosed
CN-1040321-C Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating HIV and other retroviruses UPJOHN CO (US) 1998-10-21 — — CN disclosed
EP-0758327-A1 PYRANONE COMPOUNDS USEFUL TO TREAT RETROVIRAL INFECTIONS PHARMACIA & UPJOHN COMPANY (US) 1997-02-19 — — EP disclosed
WO-1995030670-A2 PYRANONE COMPOUNDS USEFUL TO TREAT RETROVIRAL INFECTIONS PHARMACIA & UPJOHN COMPANY (US) 1995-11-16 — — WO disclosed
EP-0668860-A1 PYRAN-2-ONES AND 5,6-DIHYDROPYRAN-2-ONES USEFUL FOR TREATING HIV AND OTHER RETROVIRUSES PHARMACIA & UPJOHN COMPANY (US) 1995-08-30 — — EP disclosed
WO-1994011361-A1 PYRAN-2-ONES AND 5,6-DIHYDROPYRAN-2-ONES USEFUL FOR TREATING HIV AND OTHER RETROVIRUSES THE UPJOHN COMPANY (US) 1994-05-26 — — WO disclosed
Send feedback